Overall, IGF/IGF1R signaling is critical in PCAT6‐induced BM of PCa, which suggests that anti‐IGF1R antibody47 or antisense RNA43 may be a potentially effective therapeutic strategy for PCa patients with increased PCAT6 expression. The gene discussed is IGF1; the disease is posterior cortical atrophy.